Palisade Capital Management’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-134,296
Closed -$11.1M 450
2017
Q1
$11.1M Sell
134,296
-7,026
-5% -$591K 0.42% 74
2016
Q4
$11.9M Sell
141,322
-28,083
-17% -$2.22M 0.45% 70
2016
Q3
$13.1M Sell
169,405
-12,402
-7% -$824K 0.47% 58
2016
Q2
$10.8M Buy
181,807
+9,438
+5% +$577K 0.39% 73
2016
Q1
$10.7M Buy
172,369
+30,818
+22% +$1.85M 0.35% 90
2015
Q4
$8.61M Buy
141,551
+5,362
+4% +$348K 0.28% 119
2015
Q3
$8.28M Sell
136,189
-4,757
-3% -$276K 0.24% 147
2015
Q2
$7.85M Buy
140,946
+21,833
+18% +$1.26M 0.2% 187
2015
Q1
$6.6M Buy
119,113
+27,173
+30% +$1.56M 0.17% 219
2014
Q4
$6.13M Buy
+91,940
New +$5.74M 0.15% 250

Other funds holding BCPC

Palisade Capital Management's BCPC Position: Q2 2017 in Review

Palisade Capital Management sold out of Balchem Corp (BCPC) in Q2 2017, closing a stake of 134,296 shares — an estimated $11.1M sold.

Palisade Capital Management first reported a position in BCPC in Q4 2014 and held it in 10 quarters. The position peaked at $13.1M in Q3 2016. 202 funds tracked by Wall St. Rank hold BCPC as of Q2 2017.

  • Palisade Capital Management reported no remaining Balchem Corp position as of Q2 2017 after selling out during the quarter.
  • Palisade Capital Management sold 134,296 Balchem Corp shares in Q2 2017, an estimated $11.1M.
  • Palisade Capital Management first reported a position in Balchem Corp in Q4 2014 and held it in 10 quarters.
  • Palisade Capital Management's Balchem Corp position peaked at $13.1M in Q3 2016.
  • 202 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2017.

Based on Palisade Capital Management's 13F filing for Q2 2017, filed 1 Aug 2017.